As regulatory authorities crack down on data integrity violations, bio/pharma companies must ensure adequate data governance programs are in place.
James Davidson
Advertisement
James Davidson, PhD, is vice-president of Science and Technology at Lachman Consultants.
Articles by James Davidson
Data governance is necessary for compliance with current regulatory expectations for data integrity in pharmaceutical R&D and manufacturing organizations.
Advertisement
Latest Updated Articles
Establishing an Effective Data Governance SystemPublished: November 2nd 2017 | Updated:
- Taking a Holistic Approach for Data Governance
Published: December 6th 2017 | Updated:
Advertisement
Advertisement
